We evaluated Pfizer’s 38-page “5.3.6 Cumulative Analysis of Post-Authorization Adverse Events Reports of PF-07302048 (BNT162b2) received through 28-Feb-2021,” commonly known as “5.3.6,” starting in September of 2022. Patterns emerged across the System Organ Classes (SOCs). These patterns included Pfizer’s apparent concealment of various cases of adverse events, as well as […]
Report 92: 100s of Possible Vaccine-Associated Enhanced Disease (VAED) Cases in First 3 Months of Pfizer’s mRNA COVID Vaccine Rollout, Yet Public Health Spokespeople Minimized Their Severity by Calling Them “Breakthrough Cases.”
By late February 2021, a group of experts called Brighton Collaboration released a paper, which was published in Vaccine, clearly defining Vaccine-Associated Enhanced Disease (VAED), which is a more severe clinical presentation of a disease in a person vaccinated against that disease than would normally be seen in an unvaccinated person. Yet, […]
Report 90: Pfizer’s ‘Post-Marketing Surveillance’ Shows mRNA-Vaccinated Suffered 1000s of COVID Cases in 1st 90 Days of Vaccine Rollout. Most Infections in the Vaccinated Categorized as ‘Serious Adverse Events.’
Though spokespeople assured us that the COVID-19 injection stops — well — COVID, Pfizer and the Food and Drug Administration (FDA) both knew that during the first three months of Pfizer’s mRNA COVID-19 vaccine rollout, thousands of COVID cases were reported to Pfizer — among vaccinated people. The ‘COVID-19 Adverse […]
Report 88: 2.5 Months After COVID Vaccine Rollout, Pfizer Changed Criteria for ‘Vaccination Failure,’ Causing 99% of Reported Cases to Not Meet That Definition. 3.9% of Reported ‘Lack of Efficacy’ Cases Ended in Death in First 90 Days of Public Vaccine Availability.
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt – penned a telling analysis of the “Vaccine Effectiveness” Safety Concern section found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 […]
Report 87: In Early 2021, Pfizer Documented Significant Harms and Deaths Following Vaccination with Its mRNA COVID Vaccine. The FDA Did Not Inform the Public.
INTRODUCTION “5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162b2) Received Through 28-Feb-2021,” Pfizer’s post-marketing report, a required U.S. Food and Drug Administration (FDA) compliance document, is one of the ways in which the FDA assessed patients’ risks associated with Pfizer’s COVID-19 vaccine, BNT162b2. The data within the […]
From Clinical Trials to Histopathological Analysis: Evidence Shows COVID-19 “Vaccine” Products in Widespread Distribution Have Detrimental Effects on the Heart.
1. Cardiovascular warning signs were present in clinical trial subjects at six months. The cohort that received Pfizer’s BNT162b2 had more cardiac deaths than the non-BNT162b2 group. https://www.preprints.org/manuscript/202309.0131/v1 2. Pfizer document 3.5.6 indicates autoimmunity as the etiology (cause) of myopericarditis following BNT162b2 vaccination. 3. The government warning […]
Report 83: 23% of Vaccinated Mothers’ Fetuses or Neonates Died. Suppressed Lactation and Breast Milk Discoloration Reported.
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt – wrote a shocking analysis of the “Use in Pregnancy and Lactation” section found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of […]
US Government COVID-19 Genetic “Vaccine” Databases: Sloppy or Corrupt? Or Both?
Defense Military Epidemiology Database (DMED), Vaccine Adverse Events Reporting Systems (VAERs), and v-safe have numerous irregularities. Responsibility diffusion and secrecy have been employed to protect those involved. Lymphocytic infiltration of the myometrium (muscle layer) following COVID-19 spike-producing drugs. (Burkhardt Group Collection) It is not surprising to observe the […]
Artist Ellen Danforth Embroiders Illustration for Pfizer Reports Book Report 18: “What Did Pfizer Know, and When Did They Know It? Neurological Harms Concealed.”
DailyClout is honored that artist Ellen Danforth is working with artist Rebecca Soudant to illustrate reports from the War Room/DailyClout Pfizer Documents Analysis Reports book. Ms. Danforth embroidered the lovely piece shown in the image above as an illustration of Pfizer Report 18 in the book, “What Did Pfizer […]
International Experts Testify Again, This Time in Brazil (Porto Alegre Seminar)
The brave representative Fernanda Barth led the hearing in the Municipality of Porto Alegro along with John Kage. Many of the names you have come to love and respect were there, and I was asked by Dr Naomi Wolf to represent the 3,500 volunteers of the WarRoom/DailyClout Pfizer Document Investigations. […]
Report 78: Thirty-Two Percent of Pfizer’s Post-Marketing Respiratory Adverse Event Patients Died, Yet Pfizer Found No New Safety Signals.
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Joseph Gehrett, MD; Barbara Gehrett, MD; Chris Flowers, MD; and Loree Britt – wrote a compelling analysis of Respiratory Adverse Events of Special Interest (AESIs) found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of […]
Report 77: Women Suffered 94% of Dermatological Adverse Events Reported in First 90 Days of Pfizer COVID “Vaccine” Rollout. 80% of These Adverse Events Were Categorized As “Serious.”
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt – produced a report about Dermatological Adverse Events of Special Interest (AESIs) found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 […]
Hot Lots: “Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine” by Schmeling et al.
Dr. John Campbell discusses a March 2023 Danish research paper with one of the paper’s authors, Dr. Vibeke Manniche. The paper demonstrates that early batches of COVID-19 “vaccines” were associated with very high levels of adverse events. Dr. Manniche’s research letter can be found here: https://onlinelibrary.wiley.com/doi/10.1111/eci.13998. (Schmeling, Max, et al. […]
Report 75: mRNA COVID “Vaccines” Have Created a New Class of Multi-Organ/System Disease: “CoVax Disease.” Children from Conception on Suffer Its Devastating Effects. – Histopathology Series – Part 4d
This report is Part 4d in a series. It follows Part 1, “Report 56: Autopsies Reveal Medical Atrocities of Genetic Therapies Being Used Against a Respiratory Virus;” Part 2, “Report 58: Part 2 – “Autopsies Reveal Medical Atrocities of Genetic Therapies Being Used Against a Respiratory Virus;” and Part 3, […]
Report 73: Pfizer Knew by November 2020 That Its mRNA COVID Vaccine Was Neither Safe Nor Effective. Here Is What Pfizer’s Employees and Contractors Knew and When They Knew It.
Introduction Through the review of two documents – Pharmacovigilance Plan for Biologic License Application #125742 Of Covid-19 mRNA vaccine (nucleoside modified) (BNT162b2, PF-07302048) and 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162b2) Received Through 28-Feb-2021 – referred to below as “PV” and “5.3.6,” the contributors to this […]
Report 72: “Other AESIs” Included MERS, Multiple Organ Dysfunction Syndrome (MODS), Herpes Infections, and 96 DEATHS. 15 Patients Were Under Age 12, Including Six Infants.
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Joseph Gehrett, MD; Barbara Gehrett, MD; Chris Flowers, MD; and Loree Britt – wrote a report about Other Adverse Events of Special Interest (AESIs) found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 […]
Report 71: Musculoskeletal Adverse Events of Special Interest Afflicted 8.5% of Patients in Pfizer’s Post-Marketing Data Set, Including Four Children and One Infant. Women Affected at a Ratio of Almost 4:1 Over Men.
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt – wrote a review of musculoskeletal adverse events of special interest (AESIs) found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 […]
Report 70: Histopathology Series Part 4c – Autoimmunity: A Principal Pathological Mechanism of COVD-19 Gene Therapy Harm (CoVax Diseases) and a Central Flaw in the LNP/mRNA Platform
This report is Part 4c in a series. It follows Part 1, “Report 56: Autopsies Reveal Medical Atrocities of Genetic Therapies Being Used Against a Respiratory Virus;” Part 2, “Report 58: Part 2 – “Autopsies Reveal Medical Atrocities of Genetic Therapies Being Used Against a Respiratory Virus;” and Part 3, […]
Report 68: 34 Blood Vessel Inflammation, Vasculitis, Adverse Events Occurred in First 90 Days After Pfizer mRNA “Vaccine” Rollout, Including One Fatality. Half Had Onset Within Three Days of Injection. 81% of Sufferers Were Women.
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt – wrote an important review of vasculitis adverse events found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through […]
Report 66: 1,077 Immune-Mediated/Autoimmune Adverse Events in First 90 Days of Pfizer mRNA “Vaccine” Rollout, Including 12 Fatalities. Pfizer Undercounted This Category of Adverse Events by 270 Occurrences.
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Joseph Gehrett, MD; Barbara Gehrett, MD; Chris Flowers, MD; and Loree Britt – wrote an important review of immune-mediated/autoimmune adverse events found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through […]